IVD Test Reagent/Kits, Hematology, Coagulation, Screening, Prothrombin Time

Definition : Hematology reagents used in screening tests to determine the time required to form a fibrin clot when a sample of plasma is added to a thromboplastin-calcium mixture. Prothrombin time (PT) and the derived international normalized ratio (INR) are measures of possible factor deficiencies of the extrinsic pathway of coagulation; the reagents are used in tests to determine the clotting tendency of blood, vitamin K status, and to regulate warfarin dose.

Entry Terms : "Warfarin Dose Determination Reagents" , "PT (Prothrombin Time) Determination Reagents" , "Prothrombin Time (PT) Determination Reagents" , "Reagents, Hematology, Coagulation, Screening, Prothrombin Time"

UMDC code : 19692

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-4 of 4 Match(es).

Accriva Diagnostics

Company Type: Parent

Alere Inc

Company Type: Parent

Alere Inc., a global healthcare company, announced a new partnership with Population Services International as part of the "Make (+) Positive More Positive Campaign.

Helena Laboratories Corp

Company Type: Parent

Helena Laboratories is a clinical laboratory instrument and reagent manufacturer. Our clients include major medical centers, small hospitals, large reference laboratories and small private doctor's laboratories.

Mayo Medical Laboratories

Company Type: Parent

1-4 of 4 Match(es).

 

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone